Chi Xiao-Ling, Shi Mei-Jie, Xiao Huan-Ming, Xie Yu-Bao, Cai Gao-Shu
Hepatology Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Evid Based Complement Alternat Med. 2016;2016:3743427. doi: 10.1155/2016/3743427. Epub 2016 Jan 20.
This study aims to explore a useful noninvasive assessment containing TCM syndrome elements for liver fibrosis in CHB patients. The demographic, clinical, and pathological data were retrospectively collected from 709 CHB patients who had ALT less than 2 times the upper limit of normal from April 2009 to October 2012. Logistical regression and area under receiver-operator curve (AUROC) were used to determine the diagnostic performances of simple tests for advanced fibrosis (Scheuer stage, F ≥ 3). Results showed that the most common TCM syndrome element observed in this CHB population was dampness and Qi stagnation, followed by blood stasis, by heat, and less by Qi deficiency and Yin deficiency. The logistical regression analysis identified AST ≥ 35 IU/L, PLT ≤ 161 × 10(9)/L, and TCM syndrome element of blood stasis as the independent risk factors for advanced fibrosis. Therefore, a score model containing these three factors was established and tested. The score model containing blood stasis resulted in a higher AUC (AUC = 0.936) compared with APRI (AUC = 0.731) and FIB-4 (AUC = 0.709). The study suggested that the score model containing TCM syndrome element of blood stasis could be used as a useful diagnostic tool for advanced fibrosis in CHB patients and presented a better performance compared to APRI and FIB-4.
本研究旨在探索一种对慢性乙型肝炎(CHB)患者肝纤维化有用的包含中医证候要素的非侵入性评估方法。回顾性收集了2009年4月至2012年10月期间709例谷丙转氨酶(ALT)低于正常上限2倍的CHB患者的人口统计学、临床和病理数据。采用逻辑回归和受试者操作特征曲线下面积(AUROC)来确定晚期纤维化(Scheuer分期,F≥3)简单检测方法的诊断性能。结果显示,在该CHB人群中观察到的最常见中医证候要素是湿热蕴结,其次是瘀血阻络、肝郁化热,而气虚和阴虚则较少见。逻辑回归分析确定AST≥35 IU/L、血小板(PLT)≤161×10⁹/L以及瘀血阻络中医证候要素为晚期纤维化的独立危险因素。因此,建立并测试了包含这三个因素的评分模型。与天冬氨酸氨基转移酶与血小板比值指数(APRI)(AUROC = 0.731)和FIB-4(AUROC = 0.709)相比,包含瘀血阻络的评分模型具有更高的AUC(AUC = 0.936)。该研究表明,包含瘀血阻络中医证候要素的评分模型可作为CHB患者晚期纤维化的有用诊断工具,且与APRI和FIB-4相比表现更佳。